Please ensure Javascript is enabled for purposes of website accessibility
Zhiyuan Sun

Zhiyuan Sun


Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Fool since April 2020.

Recent articles


Near a 1-Year Low, Is Fastly a Buy?

This under-the-radar edge computing stock has more than meets the eye.


Should You Buy This Under-the-Radar Reddit Telehealth Stock?

This digital platform specializing in mental health treatments has taken its shareholders on a roller-coaster ride.


Where Will Ocugen Be in 1 Year?

This biotech underdog's dream of selling a coronavirus vaccine in the U.S. just went up in smoke.


Clean Energy Fuels: Buy at the High?

There is more than meets the eye for this energy stock.


2 Best Meme Stocks to Buy for June

Money has been flowing out of AMC Entertainment and into these up-and-coming short-squeeze candidates.


Is Tilray Headed Back to All-Time Highs?

This marijuana company was once worth more than Snapchat despite generating negligible revenue. It now seeks to make a comeback.


Could Ocugen Be a Millionaire-Maker Stock?

The ability of this biotech to sell its coronavirus vaccine in a timely manner has caused a lot of headaches for investors.


Could Clover Health Be a Millionaire-Maker Stock?

This health insurance stock has caught the attention of Reddit investors who previously propped up GameStop and AMC.


Could CureVac Be a Millionaire-Maker Stock?

This biotech's coronavirus vaccine candidate could be the next to hit the market -- but a lot of its potential success has been priced in.


Is It Too Late to Buy BioNano Genomics Stock?

Does this gene-testing biotech company have value as more than a short-squeeze play?


What's Behind This Wild-Card Coronavirus Stock?

Failure is not an option for this small-cap biotech developing a COVID-19 treatment.


Could Biogen Be a Millionaire-Maker Stock?

A new Alzheimer's drug is entering the market thanks to Biogen. But we still don't know if it is truly effective.


Is Now the Time to Sell AMC Entertainment Stock?

The movie theater operator has the potential to make an impressive comeback -- but not for the reason you might think.


Can You Count on This Popular Reddit Cancer-Treatment Stock?

Big news is coming for CEL-SCI, and we don't know which way the stock will move.


Up 20% Over a Few Days, Is Cronos a Stock You Can Count On?

Shares of this troubled marijuana grower are finally on the move, but does it mean you should buy them?


Is HEXO the Best Cannabis Stock to Buy Now?

HEXO is a company that is defying all expectations.


Is Canopy Growth a Buy?

Can investors count on this troubled marijuana producer to turn around?


What's Behind the Recent Meteoric Rise in Meme Stocks?

Behind the underdogs trying to achieve financial freedom are masterminds that match the best of Wall Street.


Down 50%, Is Novavax Stock a Great Buy Now?

This coronavirus vaccine drugmaker is having trouble getting its act together -- and has led its investors on a wild ride.


Is It Too Late to Buy Inovio Pharmaceuticals Stock?

This troubled coronavirus vaccine developer has created far more woes than joys for investors.